{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:42:10Z","timestamp":1787060530532,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370380"],"award-info":[{"award-number":["81370380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Guangdong Province of China","award":["S2013010014739"],"award-info":[{"award-number":["S2013010014739"]}]},{"name":"Innovative Foundation of Guangdong Province of China","award":["2014KZDXM020"],"award-info":[{"award-number":["2014KZDXM020"]}]},{"name":"Science and Technology Foundation of Guangzhou City of China","award":["201510010090"],"award-info":[{"award-number":["201510010090"]}]}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.yjmcc.2018.01.013","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T01:56:44Z","timestamp":1517623004000},"page":"69-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["PSRC1 overexpression attenuates atherosclerosis progression in apoE \u2212\/\u2212 mice by modulating cholesterol transportation and inflammation"],"prefix":"10.1016","volume":"116","author":[{"given":"Kai","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2018.01.013_bb0005","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S2213-8587(16)00074-7","article-title":"Recent advances in the pharmacological management of hypercholesterolaemia","volume":"4","author":"Ajufo","year":"2016","journal-title":"lancet Diabetes Endocrinol."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0015","first-page":"73","article-title":"Genetics of CHD in 2016: common and rare genetic variants and risk of CHD. Nature reviews","volume":"14","author":"Swerdlow","year":"2017","journal-title":"Cardiology"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0020","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/CIRCRESAHA.115.306246","article-title":"Microdomains, inflammation, and atherosclerosis","volume":"118","author":"Sorci-Thomas","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrcardio.2017.75","article-title":"Dyslipidaemia: PCSK9 inhibitors and foamy monocytes in familial hypercholesterolaemia","volume":"14","author":"Wu","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ajhg.2007.11.001","article-title":"Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia","volume":"82","author":"Wallace","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng.75","article-title":"Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans","volume":"40","author":"Kathiresan","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0045","first-page":"9543","article-title":"Association of variants in CELSR2-PSRC1-SORT1 with risk of serum lipid traits, coronary artery disease and ischemic stroke","volume":"8","author":"Zhou","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0050","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jjcc.2014.02.012","article-title":"CELSR2-PSRC1-SORT1 gene expression and association with coronary artery disease and plasma lipid levels in an Asian Indian cohort","volume":"64","author":"Arvind","year":"2014","journal-title":"J. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4161\/cc.9.2.10980","article-title":"DDA3: a new dancer at the growing end?","volume":"9","author":"Zhang","year":"2010","journal-title":"Cell Cycle (Georgetown, Tex)"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0060","doi-asserted-by":"crossref","first-page":"7765","DOI":"10.1038\/sj.onc.1203167","article-title":"Identification of a novel mouse p53 target gene DDA3","volume":"18","author":"Lo","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0065","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1038\/sj.onc.1205417","article-title":"Mouse DDA3 gene is a direct transcriptional target of p53 and p73","volume":"21","author":"Hsieh","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0070","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.bbrc.2008.02.047","article-title":"Human DDA3 is an oncoprotein down-regulated by p53 and DNA damage","volume":"369","author":"Hsieh","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0075","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bbrc.2008.08.168","article-title":"p53 target DDA3 binds ASPP2 and inhibits its stimulation on p53-mediated BAX activation","volume":"376","author":"Sun","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0080","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/ATVBAHA.116.308109","article-title":"Identification of genetic variants linking protein C and lipoprotein metabolism: the ARIC study (atherosclerosis risk in communities)","volume":"37","author":"Pankow","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/cge.12890","article-title":"A genetic risk score is significantly associated with statin therapy response in the elderly population","volume":"91","author":"Ciuculete","year":"2017","journal-title":"Clin. Genet."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0090","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3892\/ijmm.2015.2115","article-title":"Association of six genetic variants with myocardial infarction","volume":"35","author":"Matsuoka","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0095","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/eurheartj\/ehs344","article-title":"Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study","volume":"34","author":"Hopewell","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0100","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacc.2013.12.015","article-title":"Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese","volume":"63","author":"Lubitz","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9380290","article-title":"The impact of serum amyloid P-component on gene expression in RAW264.7 mouse macrophages","volume":"2016","author":"Xi","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0110","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4269\/ajtmh.2008.78.770","article-title":"Decreased serum paraoxonase-1 activity during intestinal nematode (Nippostrongylus brasiliensis) infection in rats","volume":"78","author":"Farid","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0115","first-page":"e1488","article-title":"Isolation of mouse peritoneal cavity cells","volume":"35","author":"Ray","year":"2010","journal-title":"J. Visual. Exp."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0120","series-title":"Current Protocols in Immunology","article-title":"The isolation and characterization of murine macrophages","author":"Zhang","year":"2008"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0130","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1161\/01.CIR.0000103624.14436.4B","article-title":"Inflammatory\/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment","volume":"108","author":"Ansell","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0135","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1161\/01.CIR.100.17.1816","article-title":"Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice","volume":"100","author":"Tangirala","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0140","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1161\/01.CIR.103.16.2096","article-title":"New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice","volume":"103","author":"Ni","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0145","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1038\/sj.onc.1210304","article-title":"p53 downstream target DDA3 is a novel microtubule-associated protein that interacts with end-binding protein EB3 and activates beta-catenin pathway","volume":"26","author":"Hsieh","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0150","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3389\/fimmu.2016.00378","article-title":"Crosstalk between Wnt\/beta-catenin and NF-kappaB signaling pathway during inflammation","volume":"7","author":"Ma","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0155","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.4049\/jimmunol.1502710","article-title":"Lck inhibits heat shock protein 65-mediated reverse cholesterol transport in T cells","volume":"197","author":"Luo","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0160","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cca.2013.06.006","article-title":"Foam cells in atherosclerosis","volume":"424","author":"Yu","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0165","doi-asserted-by":"crossref","first-page":"49982","DOI":"10.1074\/jbc.M209649200","article-title":"Scavenger receptors class A-I\/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages","volume":"277","author":"Kunjathoor","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0170","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0175","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.atherosclerosis.2014.10.012","article-title":"Heat shock protein 65 promotes atherosclerosis through impairing the properties of high density lipoprotein","volume":"237","author":"Sun","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0180","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1168974","article-title":"LXR regulates cholesterol uptake through idol-dependent ubiquitination of the LDL receptor","volume":"325","author":"Zelcer","year":"2009","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1476-511X-8-52","article-title":"Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease","volume":"8","author":"Ronald","year":"2009","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0195","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1161\/01.STR.0000226901.34927.10","article-title":"Inflammation and atherosclerosis: novel insights into plaque formation and destabilization","volume":"37","author":"Stoll","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11883-002-0025-3","article-title":"Animal models of spontaneous plaque rupture: the holy grail of experimental atherosclerosis research","volume":"4","author":"Rosenfeld","year":"2002","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0205","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/eurheartj\/ehv759","article-title":"Inflammatory cytokines in atherosclerosis: current therapeutic approaches","volume":"37","author":"Tousoulis","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0210","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1158\/0008-5472.CAN-05-3330","article-title":"Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues","volume":"66","author":"Miller","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0215","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/1440-1681.12258","article-title":"The novel role and underlying mechanism of Wnt5a in regulating cellular cholesterol accumulation","volume":"41","author":"Qin","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0220","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejphar.2015.05.023","article-title":"Wnt signaling in atherosclerosis","volume":"763","author":"Matthijs Blankesteijn","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0225","doi-asserted-by":"crossref","first-page":"33982","DOI":"10.1074\/jbc.M600135200","article-title":"A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth","volume":"281","author":"Xu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0230","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ccr.2004.08.011","article-title":"Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta","volume":"6","author":"Wang","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yjmcc.2018.01.013_bb0235","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2796.2008.01951.x","article-title":"A gut feeling of the PXR, PPAR and NF-kappaB connection","volume":"263","author":"Wahli","year":"2008","journal-title":"J. Intern. Med."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818300221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818300221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T19:14:07Z","timestamp":1719774847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282818300221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":47,"alternative-id":["S0022282818300221"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.01.013","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PSRC1 overexpression attenuates atherosclerosis progression in apoE\u2212\/\u2212 mice by modulating cholesterol transportation and inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}